SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances higher full-year revenue outlook, attributed to stronger demand for Amtagvi and Proleukin, is driving the sharp move. Traders are broadly bullish on the commercial growth signal and looking ahead to lung-cancer data, while some debate whether the rally may invite profit-taking; short-squeeze and takeover talk remains speculative.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Oracles reaffirmation of its Project Jupiter fuel-cell commitment has eased force-majeure concerns and helped drive a sharp rebound in Bloom Energy shares, keeping its AI data-center power story in focus. Traders are celebrating the recovery and speculating about short covering, while others are taking profits and warning about the stocks high valuation and volatility.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnival shares are surging after quarterly results topped expectations and the company raised its full-year outlook, supported by stronger bookings and yields. Traders are celebrating the beat, while some remain cautious about elevated fuel costs and a softer fourth-quarter earnings outlook.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for the U.S. Armys ALATTIS program to develop 10 kV silicon-carbide power semiconductors is driving attention, with traders viewing it as technology validation and a potential defense-market opportunity. The reaction is divided: bulls see a meaningful long-term milestone, while skeptics note that the awards financial terms were not disclosed and the prototype work may not deliver near-term revenue; the initial surge also gave way to volatile trading.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas strategic investment in Summit and collaboration to test ivonescimab combinations have driven attention, with traders welcoming the financing and pharma validation. The community is divided over whether the news supports further upside or could prompt a sell-the-news pullback, and many stress that the investment is not a buyout and does not resolve the separate FDA decision risk.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

The FHFAs move to allow Fannie Mae and Freddie Mac to use VantageScore alongside FICO has raised concerns that competition could weaken Fair Isaacs long-standing position in mortgage credit scoring, driving a sharp selloff. Traders debate whether the threat to FICOs business is substantial or the market reaction is an overreaction, with some pointing to its still-embedded business and others expecting pricing pressure and lost share.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

The Air Forces expanded assessment contract for Ondas-owned DZYNEs ULTRA surveillance drone is drawing attention, with traders viewing it as validation and speculating about a broader role in future military programs. Optimism over defense contracts and counter-drone deployments is tempered by frustration that the stock remains range-bound, alongside concerns about dilution and short selling.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

A breakout attempt near a long-watched support range is driving discussion, with traders debating whether VST can sustain a rebound after choppy, weak price action. Bulls point to AI data-center electricity demand and long-term power agreements, while skeptics question how quickly that demand will translate into earnings and cash flow.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQures shares are under pressure after four-year AMT-130 data for Huntingtons disease showed less slowing of progression than the three-year results, with the main measure no longer statistically significant. Traders are divided over whether this weakens the treatments prospects or whether the FDA review can still rely on the three-year data underpinning the BLA, with some attributing the later result to patient dropouts and external-control limitations.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

Positive Phase 2 results for AbCelleras ABCL635 menopause treatment, along with a planned presentation of fuller efficacy and safety data at the IMS World Congress, are driving attention. Traders are largely bullish on the drugs potential and the companys pipeline, while some caution that durability and success in larger Phase 3 trials remain unproven and the stock could pull back.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

#FIRSTLOOK 
$SPX trong leadership from transport stocks after the Durable Orders report for July showed above consensus headline growth , coupled with an upward revision to the reading from June (to 0.5% from 0.3%).  
The Dow Jones Transportation Average (+1.1%) is now up 0.6% for the week, extending its August gain to 3.1%. 
Some bargain hunting in military contractors keeping the SPDR S&amp;P Aerospace &amp; Defense ETF ($XAR 266.18, +1.34, +0.50%) on its 200-day moving average (265.59) after its recent slide from record territory.

StockTwits Web

S&P 500 Index

SPDR S&P Aerospace & Defense ETF

 trong leadership from transport stocks after the Durable Orders report for July showed above consensus headline growth , coupled with an upward revision to the reading from June (to 0.5% from 0.3%).  
The Dow Jones Transportation Average (+1.1%) is now up 0.6% for the week, extending its August gain to 3.1%. 
Some bargain hunting in military contractors keeping the SPDR S&P Aerospace & Defense ETF (

 266.18, +1.34, +0.50%) on its 200-day moving average (265.59) after its recent slide from record territory.